Extending comprehensive cancer center expertise in clinical cancer genetics and genomics to diverse communities: The power of partnership

JNCCN Journal of the National Comprehensive Cancer Network

Volumn 8, Issue 5, 2010, Pages 615-624

  MacDonald, Deborah J ^a   Blazer, Kathleen R ^a   Weitzel, Jeffrey N ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Cancer genetics; Community; Genetic counseling; Genetic education; Personalized medicine

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ARTICLE; CANCER CENTER; CANCER DIAGNOSIS; CANCER GENETICS; CANCER PREVENTION; CANCER REGISTRY; CANCER RESEARCH; CANCER RISK; CANCER SCREENING; CERTIFICATION; COLONOSCOPE; COMMUNITY; COMMUNITY ASSESSMENT; COMPUTER PROGRAM; COST EFFECTIVENESS ANALYSIS; EVIDENCE BASED MEDICINE; GENETIC ASSOCIATION; GENETIC COUNSELING; GENETIC PREDISPOSITION; GENETIC RISK; GENOMICS; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HEALTH CENTER; HEALTH PROGRAM; HUMAN; INFORMATION TECHNOLOGY; INTERNET; MASTECTOMY; MEDICAL CARE; MEDICAL EDUCATION; NATIONAL HEALTH ORGANIZATION; RISK ASSESSMENT; RISK REDUCTION; SALPINGOOOPHORECTOMY; TELEMEDICINE; VIDEOCONFERENCING;

EID: 77952993986     PISSN: 15401405     EISSN: 15401413     Source Type: Journal    
DOI: 10.6004/jnccn.2010.0046     Document Type: Article

References (43)

1. Weitzel JN. Genetic cancer risk assessment: putting it all together. Cancer 1999;86(11 Suppl):2483-2492. (Pubitemid 30007531)
2. Lippman SM, Hawk ET. Cancer prevention: from 1727 to milestones of the past 100 years. Cancer Res 2009;69:5269-5284.
3. Institute of Medicine (IOM). Cancer-related genetic testing and counseling: workshop proceedings. Institute of Medicine: Washington, DC; 2007.
4. DeMarco TA, Smith KL, Nusbaum RH, et al. Practical aspects of delivering hereditary cancer risk counseling. Semin Oncol 2007;34:369-378.
5. Halben CH, Lynch H, Lynch J, et al. Colon cancer screening practices following genetic testing for hereditary nonpolyposis colon cancer (HNPCC) mutations. Arch Intern Med 2004;164:1881-1887.
6. Warner E, Messersmith H, Causer P, et al. Systematic review: using magnetic resonance imaging to screen women at high risk for breast cancer. Ann Intern Med 2008;148:671-679. (Pubitemid 351669112)
7. Narod SA, Brunet JS, Ghadirian P, et al. Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group. Lancet 2000;356:1876-1881.
8. Rebbeck TR, Friebel T, Lynch HT, et al. Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE study group. J Clin Oncol 2004;22:1055-1062. (Pubitemid 41095038)
9. Finch A, Beiner M, Lubinski J, et al. Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 mutation. JAMA 2006;296:185-192.
10. Rebbeck TR, Kauff ND, Domchek SM. Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers. J Natl Cancer Inst 2009;101:80-87.
11. Fong PC, Boss DS, Yap TA, et al. Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers. N Engl J Med 2009;361:1-12.
12. Lynch HT, Casey MJ, Snyder CL, et al. Hereditary ovarian carcinoma: heterogeneity, molecular genetics, pathology, and management. Mol Oncol 2009;3:97-137.
13. Markowitz SD, Bertagnolli MM. Molecular basis of colorectal cancer. N Engl J Med 2009;361:2449-2460.
14. Jarvinen HJ, Renkonen-Sinisalo L, Aktan-Collan K, et al. Ten years after mutation testing for Lynch syndrome: cancer incidence and outcome in mutation-positive and mutation-negative family members. J Clin Oncol 2009;27:4793-4797.
15. Flowers CR, Veenstra D. The role of cost-effectiveness analysis in the era of pharmacogenomics. Pharmacoeconomics 2004;22:481-493. (Pubitemid 38858292)
16. Yang Q, Randers WD, Moonesinghe R, et al. Using lifetime risk estimates in personal genomic profiles: estimation of uncertainty. Am J Hum Genet 2009;85:786-800.
17. Robson M, Storm C, Weitzel JN, et al. American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility. J Clin Oncol 2010;28;893-901.
18. Evans JP. Health care in the age of genetic medicine. JAMA 2007;298:2670-2672. (Pubitemid 350254960)
19. Ng PC, Murray SS, Levy S, Venter JC. An agenda for personalized medicine. Nature 2009;461:724-726.
20. Burke W, Psaty BM. Personalized medicine in the era of genomics. JAMA 2007;298:1682-1684.
21. MacDonald DJ, Sand S, Kass FC, et al. The power of partnership: extending comprehensive cancer center expertise in clinical cancer genetics to breast care in community centers. Semin Breast Dis 2006;9:39-47.
22. Zon RT, Goss E, Vogel VG, et al. American Society of Clinical Oncology policy statement: the role of the oncologist in cancer prevention and risk assessment. J Clin Oncol 2009;27:986-993.
23. Geier LJ, Mulvey TM, Weitzel JN. Clinical cancer genetics remains a specialized area: how do I get there from here? ASCO 2009 Educational Book: Practice Management and Information Technology. Alexandria, VA: American Society of Clinical Oncology; 2009.
24. Wham D, Vu T, Chan-Smutko G, et al. Assessment of clinical practices among cancer genetic counselors. Fam Cancer 2010; in press.
25. Cohen SA, McIlvried D, Schnieders J. A collaborative approach to genetic testing: a community hospital's experience. J Genet Couns 2009;18:530-533.
26. Allain D, Baker M, Blazer K, et al. Evolving models of cancer risk genetic counseling. Perspectives in Genetic Counseling 2010;in press.
27. Blazer KR, Grant M, Sand SR, et al. Development of a cancer genetics education program for clinicians. J Cancer Educ 2002;17:69-73.
28. Weitzel JN, Lagos VI, Herzog JS, et al. Evidence for common ancestral origin of a recurring BRCAl genomic rearrangement identified in high-risk Hispanic families. Cancer Epidemiol Biomarkers Prev 2007;16:1615-1620.
29. Daly MB, Axilbund JE, Bryant E, et al. NCCN clinical practice guidelines in oncology: genetic/familial high-risk assessment: breast and ovarian, version 1, 2009. Available at: http://www.nccn.org/ professionals/physician-gls/PDF/ genetics-screening.pdf. Accessed June 15, 2009.
30. Weitzel JN, Lagos VI, Cullinane CA, et al. Limited family structure and BRCA gene mutation status in single cases of breast cancer. JAMA 2007;297:2587-2595.
31. Ricker C, Lagos V, Feldman N, et al. If we build it ... will they come? - establishing a cancer genetics services clinic for an underserved predominantly Latina cohort. J Genet Couns 2006;15:505-514.
32. Lagos VI, Perez MA, Ricker CN, et al. Social cognitive aspects of underserved Latinas preparing to undergo genetic risk assessment for hereditary breast and ovarian cancer. Psychooncology 2008;17:774-782.
33. Ho C. How to develop and implement a cancer genetics risk assessment program: clinical and economic considerations. Oncology Issues 2004;19:22-26.
34. Pirzadeh S. Starting a cancer genetics clinic in a county hospital. Oncology Issues 2009;24:38-43.
35. MacDonald DJ. Establishing a cancer genetics service. In: Kuerer H, ed. Kuerer's Breast Surgical Oncology. 1st ed. New York: McGraw-Hill; In Press.
36. ASCO Curriculum Cancer Genetics & Cancer Predisposition Testing. 1st ed. Alexandria, VA: ASCO Publishing; 1998.
37. ASCO Curriculum Cancer Genetics &. Cancer Predisposition Testing. 2nd ed. Alexandria, VA: ASCO Publishing; 2004.
38. Blazer KR, MacDonald DJ, Ricker C, et al. Outcomes from intensive training in genetic cancer risk counseling for clinicians. Genet Med 2005;7:40-47.
39. Lagos VI, Blazer KR, Viveros L, et al. Impact of genetic cancer risk assessment on cancer screening and prevention behaviors in an underserved predominantly Latina population [abstract]. Presented at the National Latino Cancer Summit; San Francisco, California; July 31, 2008.
40. ACOG Practice Bulletin No. 103: hereditary breast and ovarian cancer syndrome. Obstet Gynecol 2009; 113:957-966.
41. Oncology Nursing Society. Cancer Predisposition Genetic Testing and Risk Assessment Counseling. Available at: http://www.ons.org/ Publications/Positions/ Predisposition. Accessed March 9, 2010.
42. Trepanier A, Ahrens M, McKinnon W, et al. Genetic cancer risk assessment and counseling: recommendations of the National Society of Genetic Counselors. J Genet Couns 2004 2004; 13:83-114.
43. Burt RW, Barthel JS, Dunn KB, et al. NCCN clinical practice guidelines in oncology: colorectal cancer screening, version I, 2010. Available at: http://www.nccn.org/professionals/physician- gls/PDF/colorectal-screening.pdf. Accessed March 9, 2010.